Susquehanna Portfolio Strategies’s Sana Biotechnology SANA Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$482K	Hold	167,503	–	–	0.01%	766
2025 Q4	$682K	Hold	167,503	–	–	0.01%	715
2025 Q3	$595K	Sell	167,503 -3,320	-2%	-$12K	0.01%	791
2025 Q2	$466K	Buy	+170,823	New	+$352K	0.01%	668
2024 Q4	–	Sell	-81,695	Closed	-$340K	–	269
2024 Q3	$340K	Hold	81,695	–	–	0.02%	277
2024 Q2	$446K	Hold	81,695	–	–	0.02%	374
2024 Q1	$817K	Sell	81,695 -141,443	-63%	-$1.06M	0.02%	498
2023 Q4	$910K	Buy	+223,138	New	+$822K	0.02%	623

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

IHAM

Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Susquehanna Portfolio Strategies's SANA Position: Q1 2026 in Review

Susquehanna Portfolio Strategies held its Sana Biotechnology (SANA) position steady in Q1 2026 at 167,503 shares worth $482K. The position accounts for 0.01% of the portfolio, ranked #766.

Susquehanna Portfolio Strategies first reported a position in SANA in Q4 2023 and has held it in 8 quarters since. The position peaked at $910K in Q4 2023. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

Susquehanna Portfolio Strategies held 167,503 shares of Sana Biotechnology worth $482K as of Q1 2026.
Susquehanna Portfolio Strategies left its Sana Biotechnology share count unchanged in Q1 2026.
Sana Biotechnology made up 0.01% of Susquehanna Portfolio Strategies's portfolio in Q1 2026, its #766 holding.
Susquehanna Portfolio Strategies first reported a position in Sana Biotechnology in Q4 2023 and has held it in 8 quarters since.
Susquehanna Portfolio Strategies's Sana Biotechnology position peaked at $910K in Q4 2023.
202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.